Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 846.76 | 258 / 258 | 99% | 31.94 | 227 / 230 |
| thymus | 100% | 679.03 | 652 / 653 | 99% | 28.00 | 598 / 605 |
| intestine | 100% | 783.22 | 966 / 966 | 99% | 27.97 | 520 / 527 |
| brain | 99% | 725.01 | 2624 / 2642 | 99% | 24.51 | 700 / 705 |
| prostate | 100% | 666.43 | 244 / 245 | 98% | 23.79 | 494 / 502 |
| ovary | 100% | 422.38 | 180 / 180 | 98% | 28.36 | 420 / 430 |
| kidney | 100% | 820.89 | 89 / 89 | 97% | 21.50 | 877 / 901 |
| liver | 100% | 530.69 | 226 / 226 | 97% | 21.08 | 395 / 406 |
| stomach | 100% | 596.59 | 358 / 359 | 98% | 23.48 | 279 / 286 |
| esophagus | 100% | 854.49 | 1445 / 1445 | 97% | 17.23 | 178 / 183 |
| bladder | 100% | 740.24 | 21 / 21 | 97% | 28.82 | 490 / 504 |
| skin | 99% | 592.85 | 1798 / 1809 | 97% | 21.14 | 458 / 472 |
| lung | 99% | 540.94 | 571 / 578 | 96% | 22.12 | 1110 / 1155 |
| uterus | 100% | 691.38 | 170 / 170 | 95% | 28.95 | 435 / 459 |
| breast | 100% | 657.77 | 459 / 459 | 94% | 15.66 | 1055 / 1118 |
| pancreas | 96% | 325.30 | 315 / 328 | 97% | 23.43 | 173 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 34.62 | 29 / 29 |
| muscle | 100% | 3674.84 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 578.28 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 32.58 | 1 / 1 |
| adipose | 100% | 728.89 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| heart | 100% | 1570.56 | 858 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 742.23 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 29.39 | 79 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 24.32 | 44 / 45 |
| peripheral blood | 50% | 229.26 | 462 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0044255 | Biological process | cellular lipid metabolic process |
| GO_0070328 | Biological process | triglyceride homeostasis |
| GO_0006635 | Biological process | fatty acid beta-oxidation |
| GO_0051146 | Biological process | striated muscle cell differentiation |
| GO_0045333 | Biological process | cellular respiration |
| GO_0010918 | Biological process | positive regulation of mitochondrial membrane potential |
| GO_0051284 | Biological process | positive regulation of sequestering of calcium ion |
| GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
| GO_0032000 | Biological process | positive regulation of fatty acid beta-oxidation |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MTLN |
| Protein name | Mitoregulin (Micropeptide in mitochondria) (Micropeptide regulator of beta-oxidation) (Small integral membrane protein 37) (lncRNA-encoded micropeptide) |
| Synonyms | LINC00116 SMIM37 NCRNA00116 MOXI LEMP MPM |
| Description | FUNCTION: Positively regulates mitochondrial complex assembly and/or stability (By similarity). Increases mitochondrial membrane potential while decreasing mitochondrial reactive oxygen species . Increases mitochondrial respiration rate . Increased mitochondrial respiratory activity promotes myogenic differentiation which facilitates muscle growth and regeneration (By similarity). Increases mitochondrial calcium retention capacity . Plays a role in maintenance of cellular lipid composition through its interaction with cytochrome b5 reductase CYB5R3 which is required for mitochondrial respiratory complex I activity (By similarity). Interacts with the mitochondrial trifunctional enzyme complex (MTE) and enhances fatty acid beta-oxidation . Not required for MTE formation or stability (By similarity). Modulates triglyceride clearance in adipocytes through its role in regulating fatty acid beta-oxidation and lipolysis . . |
| Accessions | Q8NCU8 ENST00000414416.2 [Q8NCU8-1] ENST00000426713.1 [Q8NCU8-2] ENST00000611969.5 [Q8NCU8-2] |